EH0202

clinically improved menopausal symptoms in post-menopausal women & appears to help maintain normal biological function and improves quality of life; contains a proprietary blend of four herbs & Bifidobacterium longum

Also Known As:

MACH herbal supplement

Networked: 2 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - EH0202: 2
Pharmaceutical Preparations
- Plant Extracts: 3916
  - EH0202: 2

Experts

1.	Yoshida, Satoshi: 2 articles (09/2004 - 01/2004)
2.	Honda, Masao: 1 article (09/2004)
3.	Kaji, Kyosuke: 1 article (09/2004)
4.	Kaneko, Shuichi: 1 article (09/2004)
5.	Kojima, Yasuhiko: 1 article (09/2004)
6.	Mizukoshi, Eishiro: 1 article (09/2004)
7.	Nagata, Nobuo: 1 article (09/2004)
8.	Yamashita, Tatsuya: 1 article (09/2004)
9.	Ikeda, Atsushi: 1 article (01/2004)
10.	Tadaki, Keiichi: 1 article (01/2004)

Related Diseases

1.	Chronic Hepatitis C 09/01/2004 - "These findings suggest that EH0202 may be safe and useful in the treatment of patients with chronic hepatitis C. " 09/01/2004 - "An open-label study of administration of EH0202, a health-food additive, to patients with chronic hepatitis C." 09/01/2004 - "In this study, we examined the effect of EH0202, a mixture of four herbal extracts that are known to induce interferons, on hepatitis C virus (HCV)-RNA levels in patients with chronic hepatitis C. "
2.	Flushing 01/01/2004 - "EH0202 (MACH) reduced blood pressure, excess facial skin blood flow (flushing) and abnormal lipid levels, as well as clinically improved menopausal symptoms in post-menopausal women. "
3.	Vomiting 09/01/2004 - "Among the 35 patients who successfully completed the study, there were improvements in malaise (seen in 6 patients before and in 2 after EH0202 treatment), bloating sensation in the abdomen (seen in 2 before and in none after treatment), and nausea and vomiting (seen in 2 before and in 1 after treatment). "
4.	Nausea 09/01/2004 - "Among the 35 patients who successfully completed the study, there were improvements in malaise (seen in 6 patients before and in 2 after EH0202 treatment), bloating sensation in the abdomen (seen in 2 before and in none after treatment), and nausea and vomiting (seen in 2 before and in 1 after treatment). "

Related Drugs and Biologics

1.	Lipids
2.	RNA (Ribonucleic Acid)
3.	Interferons
4.	Food Additives (Food Additive)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)